artificial intelligence
Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.
Cedars-Sinai, Tempus Partner on Molecular Database Initiative
The partners launched the Molecular Twin initiative to collect cancer patients' DNA, RNA, and protein information and use it to inform treatment and advance research.
The molecular diagnostics company seeks to automate its customers' pipelines with AI and diversify beyond hematology.
Sophia Genetics Q2 Revenue Grows 72 Percent
In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO.
Kiromic BioPharma Acquires InSilico Solutions
Kiromic expects the acquisition of the custom bioinformatics technology developer to facilitate new cancer immunotherapy discovery.
Jul 21, 2021
Jul 19, 2021
Sophia Genetics Increases IPO Target to $221M
Jul 8, 2021
Jun 24, 2021
Jun 15, 2021
Jun 10, 2021
May 26, 2021